CompletedNot Applicable

Efficacy of Repetitive Trans-spinal Magnetic Stimulation on Axial Motor Symptoms in PD

Egypt38 participantsStarted 2023-01-01

Plain-language summary

The purpose of this randomized trial was to evaluate the efficacy of repeated sessions of trans-spinal magnetic stimulation on gait abnormality, and posture abnormalities in patients with idiopathic Parkinson's disease.

Who can participate

Age range40 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Men or women of at least 40-80 years of age.
✓. Are reliable and willing to make themselves available for the duration of the study and are willing to follow up.
✓. Medically stable outpatients with a confirmed diagnosis of idiopathic PD according to United Kingdom Brain Bank Criteria
✓. Clear written informed consent from each participant in the trial.
✓. Patients after at least 6 h free of parkinsonian drugs (off-state).

Exclusion criteria

✕. Pregnants, breastfeeding, or willing to be pregnant during the study.
✕. Presence of a clinically significant medical or psychiatric condition that may increase the risk associated with the study
✕. Participation in any other type of medical research that may interfere with the interpretation of the study.
✕. Patients with severe motor disability (bed-ridden ) that may interfere with the study procedure.
✕. History of surgical or invasive intervention for Parkinson's disease.
✕. Patients with a history of seizures or epilepsy including history in a first-degree relative or patients on treatment that reduce the seizure threshold.

What they're measuring

Score on Freezing of gait Questionnaire

Timeframe: 2 months after the end of sessions

Time taken for Primed up-and-go

Timeframe: 2 months after the end of sessions

Time taken for 10m walk

Timeframe: 2 months after the end of sessions

Trial details

NCT IDNCT05271513

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-05-01

View on ClinicalTrials.gov More Adverse Effect of Drug Therapy Levodopa trials

Who can participate

Age range40 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Men or women of at least 40-80 years of age.
✓. Are reliable and willing to make themselves available for the duration of the study and are willing to follow up.
✓. Medically stable outpatients with a confirmed diagnosis of idiopathic PD according to United Kingdom Brain Bank Criteria
✓. Clear written informed consent from each participant in the trial.
✓. Patients after at least 6 h free of parkinsonian drugs (off-state).

Exclusion criteria

✕. Pregnants, breastfeeding, or willing to be pregnant during the study.
✕. Presence of a clinically significant medical or psychiatric condition that may increase the risk associated with the study
✕. Participation in any other type of medical research that may interfere with the interpretation of the study.
✕. Patients with severe motor disability (bed-ridden ) that may interfere with the study procedure.
✕. History of surgical or invasive intervention for Parkinson's disease.
✕. Patients with a history of seizures or epilepsy including history in a first-degree relative or patients on treatment that reduce the seizure threshold.